Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Variant calling on matched primary and metastatic tumor without normal samples.

    Hello!

    I have exome sequencing data for 20 pairs of primary and matched metastatic tumors coming different patients. However, I have no Normal samples.

    I am interested in looking at mutation evolution from the primary to metastatic samples. What would be the best strategy to call variants? The way I see it, I have two options:

    1) Call variants using the primary sample as the control sample for their matched metastatic sample and use the metastatic sample as the normal for the primary sample.

    2) Follow the TCGA workflow for Tumor-Only variant calling and just call the samples independently. https://docs.gdc.cancer.gov/Data/Bio...ation-workflow

    3) Would it make more sense to create a "Panel of Normals" for each patient using the matched primary and metastatic tumor?

    I would like to hear your thoughts on how to approach this problem. thank you all in advance for the advice!!!

Latest Articles

Collapse

  • seqadmin
    Current Approaches to Protein Sequencing
    by seqadmin


    Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
    04-04-2024, 04:25 PM
  • seqadmin
    Strategies for Sequencing Challenging Samples
    by seqadmin


    Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
    03-22-2024, 06:39 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 04-11-2024, 12:08 PM
0 responses
18 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-10-2024, 10:19 PM
0 responses
22 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-10-2024, 09:21 AM
0 responses
16 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-04-2024, 09:00 AM
0 responses
47 views
0 likes
Last Post seqadmin  
Working...
X